Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease. - Bénardeau A; Kahnert A; Schomber T; Meyer J; Pavkovic M; Kretschmer A; Lawrenz B; Hartmann E; Mathar I; Hueser J; Kraehling JR; Eitner F; et al. (Naunyn-Schmiedeberg's archives of pharmacology, 2021)